Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arvinas, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arvinas, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Norwalk Leslie V | Director | 41,572 | Jun 26, 2026 | 1 |
| Cunningham Everett | Director | 41,572 | Jun 26, 2026 | 1 |
| Bain Linda | Director | 41,572 | Jun 26, 2026 | 1 |
| Smaldone Alsup Laurie | Director | 41,572 | Jun 26, 2026 | 1 |
| Morrison Briggs | Director | 111,548 | Jun 26, 2026 | 2 |
| Kennedy Edward Moore Jr. | Director | 54,957 | Jun 26, 2026 | 1 |
| Saik Andrew | Chief Financial Officer | 187,432 | Jun 24, 2026 | 4 |
| Cacace Angela M | Chief Scientific Officer | 180,390 | Jun 18, 2026 | 5 |
| Teel Randy | President and CEO | 285,009 | May 22, 2026 | 5 |
| Berkowitz Noah | Chief Medical Officer | 191,395 | May 13, 2026 | 4 |
| Loomis David K | VP, Chief Accounting Officer | 40,193 | May 13, 2026 | 5 |
| Houston John G | Director | 1,122,183 | Mar 2, 2026 | 1 |
| Agarwal Sunil | Director | 30,166 | Jun 30, 2025 | 0 |
| Young John D | Director | 26,045 | Jun 27, 2025 | 0 |
| Taylor Ian | President, R&D | 159,121 | Feb 25, 2025 | 0 |
| Cassidy Sean A | Chief Financial Officer | 181,916 | Feb 27, 2024 | 0 |
| Peck Ronald | Chief Medical Officer | 67,516 | Feb 27, 2024 | 0 |
| Dixon Wendy L | Director | 9,121 | Jun 20, 2023 | 0 |
| Shannon Timothy M | Director | 1,653,128Indirect | Jun 21, 2022 | 0 |
| Ratcliffe Liam | Director | 185,686Indirect | Jun 21, 2022 | 0 |
| Margus Bradley Albert | Director | 2,000Indirect | Jun 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Teel RandyPresident and CEO | SSale | −4.79K | $12.16 | −$58.2K | −3.1%149.7K after | 2 lots |
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Cacace Angela MChief Scientific Officer | SSale | −3.61K | $12.16 | −$43.9K | −2.4%147.6K after | 2 lots |
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Loomis David KChief Accounting Officer | SSale | −1.11K | $12.16 | −$13.5K | −3.6%29.7K after | |
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Houston John GDirector | SSale | −35.3K | $13.21 | −$466.2K | −3.0%1.12M after | 3 lots |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | Morrison BriggsDirector | PPurchase | +20.0K | $13.40 | +$268.0K | +26.3%96.0K after | |
| Mar 19, 2026 (view filing) | Mar 18 | 1 day | Berkowitz NoahChief Medical Officer | SSale | −6.43K | $11.10 | −$71.4K | −3.1%202.5K after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Teel RandyPresident and CEO | SSale | −9.66K | $9.94 | −$96.0K | −3.3%287.2K after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Berkowitz NoahChief Medical Officer | SSale | −11.1K | $9.94 | −$110.4K | −5.5%191.4K after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Cacace Angela MChief Scientific Officer | SSale | −9.66K | $9.94 | −$96.0K | −5.0%183.0K after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Loomis David KVP, Chief Accounting Officer | SSale | −1.92K | $9.94 | −$19.1K | −4.6%40.2K after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Saik AndrewChief Financial Officer | SSale | −11.1K | $9.94 | −$110.7K | −5.5%193.1K after | |
| May 22, 2026 (view filing) | May 21 | 1 day | Teel RandyPresident and CEO | SSale | −2.21K | $9.04 | −$20.0K | −0.8%285.0K after | |
| Jun 18, 2026 (view filing) | Jun 17 | 1 day | Cacace Angela MChief Scientific Officer | SSale | −2.58K | $7.60 | −$19.6K | −1.4%180.4K after | 10b5-1 |
| Jun 24, 2026 (view filing) | Jun 24 | Same day | Saik AndrewChief Financial Officer | SSale | −5.70K | $8.16 | −$46.5K | −2.9%187.4K after | 10b5-1 |